News
Ocular Therapeutix’ investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback